Trial intelligence / Profile preview

ROADS: Ropivacaine Concentrations for Ultrasound-guided Ankle Blocks in Hallux Valgus Repair

NCT06185608Recruiting

Sponsor
Ziekenhuis Oost-Limburg
Start
May 2025
Primary completion
May 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of ropivacaine in Anesthesia (3 arms), sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Duration of sensory block at 48 hours. Started May 2025; status: recruiting.

02

Drugs

ropivacaine
03

Conditions

Anesthesia

Beyond the preview

Go deeper on NCT06185608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06185608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call